Literature DB >> 12354622

When reverse genetics meets physiology: the use of site-specific recombinases in mice.

François Tronche1, Emilio Casanova, Marc Turiault, Iman Sahly, Christoph Kellendonk.   

Abstract

The use of site-specific recombinases enables the precise introduction of defined genetic mutations into the mouse genome. In theory, any deletion, point mutation, inversion or translocation can be modeled in mice. Because gene targeting is controlled both spatially and temporally, the function of a given gene can be studied in the desired cell types and at a specific time point. This 'genetic dissection' allows to define gene function in development, physiology or behavior. In this review, we focus on the technical possibilities of Cre and other site-specific recombinases but also discuss their limitations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354622     DOI: 10.1016/s0014-5793(02)03266-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Inducible excision of selectable marker gene from transgenic plants by the cre/lox site-specific recombination system.

Authors:  Yong Wang; Bojun Chen; Yuanlei Hu; Jingfu Li; Zhongping Lin
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

2.  Multiple levels of affinity-dependent DNA discrimination in Cre-LoxP recombination.

Authors:  Kathy A Gelato; Shelley S Martin; Scott Wong; Enoch P Baldwin
Journal:  Biochemistry       Date:  2006-10-10       Impact factor: 3.162

Review 3.  Physiological consequences of defects in ERCC1-XPF DNA repair endonuclease.

Authors:  Siobhán Q Gregg; Andria Rasile Robinson; Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2011-05-25

4.  Long-range chromosomal engineering is more efficient in vitro than in vivo.

Authors:  Lisa E Olson; Jason Tien; Sarah South; Roger H Reeves
Journal:  Transgenic Res       Date:  2005-06       Impact factor: 2.788

5.  Reversed DNA strand cleavage specificity in initiation of Cre-LoxP recombination induced by the His289Ala active-site substitution.

Authors:  Kathy A Gelato; Shelley S Martin; Enoch P Baldwin
Journal:  J Mol Biol       Date:  2005-10-05       Impact factor: 5.469

Review 6.  Gene-targeting technologies for the study of neurological disorders.

Authors:  Vassilios Beglopoulos; Jie Shen
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

7.  Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.

Authors:  Jay P McLaughlin; Benjamin B Land; Shuang Li; John E Pintar; Charles Chavkin
Journal:  Neuropsychopharmacology       Date:  2006-04       Impact factor: 7.853

8.  Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.

Authors:  Jay P McLaughlin; Monica Marton-Popovici; Charles Chavkin
Journal:  J Neurosci       Date:  2003-07-02       Impact factor: 6.167

9.  A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivo.

Authors:  Sandra Morandell; H Christian Reinhardt; Ian G Cannell; Jacob S Kim; Daniela M Ruf; Tanya Mitra; Anthony D Couvillon; Tyler Jacks; Michael B Yaffe
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

10.  Unidirectional Cre-mediated genetic inversion in mice using the mutant loxP pair lox66/lox71.

Authors:  Philipp Oberdoerffer; Kevin L Otipoby; Mitsuo Maruyama; Klaus Rajewsky
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.